COVID-19 Impact on Global Inflammatory Bowel Disease Therapy Market Size, Status and Forecast 2020-2026

August 2020 | 99 pages | ID: C03042A01FE5EN
QYResearch

Abstracts

This report focuses on the global Inflammatory Bowel Disease Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Inflammatory Bowel Disease Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Johnson & Johnson
• AbbVie
• Takeda Pharmaceutical Company
• Abbott
• Celgene Corporation
• Innovate Biopharma
• Cosmo Pharmaceuticals
• Gilead Sciences
• Pfizer

Market segment by Type, the product can be split into

• Ulcerative Colitis
• Crohns Disease
• Others

Market segment by Application, split into

• Hospital
• Medical Research Organization
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Inflammatory Bowel Disease Therapy status, future forecast, growth opportunity, key market and key players.
• To present the Inflammatory Bowel Disease Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Inflammatory Bowel Disease Therapy are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Inflammatory Bowel Disease Therapy Revenue
1.4 Market Analysis by Type
  1.4.1 Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Ulcerative Colitis
  1.4.3 Crohns Disease
  1.4.4 Others
1.5 Market by Application
  1.5.1 Global Inflammatory Bowel Disease Therapy Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Medical Research Organization
  1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Inflammatory Bowel Disease Therapy Industry Impact
  1.6.1 How the Covid-19 is Affecting the Inflammatory Bowel Disease Therapy Industry
    1.6.1.1 Inflammatory Bowel Disease Therapy Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Inflammatory Bowel Disease Therapy Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Inflammatory Bowel Disease Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Inflammatory Bowel Disease Therapy Market Perspective (2015-2026)
2.2 Inflammatory Bowel Disease Therapy Growth Trends by Regions
  2.2.1 Inflammatory Bowel Disease Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Inflammatory Bowel Disease Therapy Historic Market Share by Regions (2015-2020)
  2.2.3 Inflammatory Bowel Disease Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Inflammatory Bowel Disease Therapy Market Growth Strategy
  2.3.6 Primary Interviews with Key Inflammatory Bowel Disease Therapy Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Inflammatory Bowel Disease Therapy Players by Market Size
  3.1.1 Global Top Inflammatory Bowel Disease Therapy Players by Revenue (2015-2020)
  3.1.2 Global Inflammatory Bowel Disease Therapy Revenue Market Share by Players (2015-2020)
  3.1.3 Global Inflammatory Bowel Disease Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Inflammatory Bowel Disease Therapy Market Concentration Ratio
  3.2.1 Global Inflammatory Bowel Disease Therapy Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease Therapy Revenue in 2019
3.3 Inflammatory Bowel Disease Therapy Key Players Head office and Area Served
3.4 Key Players Inflammatory Bowel Disease Therapy Product Solution and Service
3.5 Date of Enter into Inflammatory Bowel Disease Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Inflammatory Bowel Disease Therapy Historic Market Size by Type (2015-2020)
4.2 Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Type (2021-2026)

5 INFLAMMATORY BOWEL DISEASE THERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020)
5.2 Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Inflammatory Bowel Disease Therapy Market Size (2015-2020)
6.2 Inflammatory Bowel Disease Therapy Key Players in North America (2019-2020)
6.3 North America Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020)
6.4 North America Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Inflammatory Bowel Disease Therapy Market Size (2015-2020)
7.2 Inflammatory Bowel Disease Therapy Key Players in Europe (2019-2020)
7.3 Europe Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020)
7.4 Europe Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020)

8 CHINA

8.1 China Inflammatory Bowel Disease Therapy Market Size (2015-2020)
8.2 Inflammatory Bowel Disease Therapy Key Players in China (2019-2020)
8.3 China Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020)
8.4 China Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Inflammatory Bowel Disease Therapy Market Size (2015-2020)
9.2 Inflammatory Bowel Disease Therapy Key Players in Japan (2019-2020)
9.3 Japan Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020)
9.4 Japan Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Inflammatory Bowel Disease Therapy Market Size (2015-2020)
10.2 Inflammatory Bowel Disease Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020)

11 INDIA

11.1 India Inflammatory Bowel Disease Therapy Market Size (2015-2020)
11.2 Inflammatory Bowel Disease Therapy Key Players in India (2019-2020)
11.3 India Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020)
11.4 India Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Inflammatory Bowel Disease Therapy Market Size (2015-2020)
12.2 Inflammatory Bowel Disease Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020)
12.4 Central & South America Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Johnson & Johnson
  13.1.1 Johnson & Johnson Company Details
  13.1.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.1.3 Johnson & Johnson Inflammatory Bowel Disease Therapy Introduction
  13.1.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020))
  13.1.5 Johnson & Johnson Recent Development
13.2 AbbVie
  13.2.1 AbbVie Company Details
  13.2.2 AbbVie Business Overview and Its Total Revenue
  13.2.3 AbbVie Inflammatory Bowel Disease Therapy Introduction
  13.2.4 AbbVie Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020)
  13.2.5 AbbVie Recent Development
13.3 Takeda Pharmaceutical Company
  13.3.1 Takeda Pharmaceutical Company Company Details
  13.3.2 Takeda Pharmaceutical Company Business Overview and Its Total Revenue
  13.3.3 Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Introduction
  13.3.4 Takeda Pharmaceutical Company Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020)
  13.3.5 Takeda Pharmaceutical Company Recent Development
13.4 Abbott
  13.4.1 Abbott Company Details
  13.4.2 Abbott Business Overview and Its Total Revenue
  13.4.3 Abbott Inflammatory Bowel Disease Therapy Introduction
  13.4.4 Abbott Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020)
  13.4.5 Abbott Recent Development
13.5 Celgene Corporation
  13.5.1 Celgene Corporation Company Details
  13.5.2 Celgene Corporation Business Overview and Its Total Revenue
  13.5.3 Celgene Corporation Inflammatory Bowel Disease Therapy Introduction
  13.5.4 Celgene Corporation Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020)
  13.5.5 Celgene Corporation Recent Development
13.6 Innovate Biopharma
  13.6.1 Innovate Biopharma Company Details
  13.6.2 Innovate Biopharma Business Overview and Its Total Revenue
  13.6.3 Innovate Biopharma Inflammatory Bowel Disease Therapy Introduction
  13.6.4 Innovate Biopharma Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020)
  13.6.5 Innovate Biopharma Recent Development
13.7 Cosmo Pharmaceuticals
  13.7.1 Cosmo Pharmaceuticals Company Details
  13.7.2 Cosmo Pharmaceuticals Business Overview and Its Total Revenue
  13.7.3 Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Introduction
  13.7.4 Cosmo Pharmaceuticals Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020)
  13.7.5 Cosmo Pharmaceuticals Recent Development
13.8 Gilead Sciences
  13.8.1 Gilead Sciences Company Details
  13.8.2 Gilead Sciences Business Overview and Its Total Revenue
  13.8.3 Gilead Sciences Inflammatory Bowel Disease Therapy Introduction
  13.8.4 Gilead Sciences Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020)
  13.8.5 Gilead Sciences Recent Development
13.9 Pfizer
  13.9.1 Pfizer Company Details
  13.9.2 Pfizer Business Overview and Its Total Revenue
  13.9.3 Pfizer Inflammatory Bowel Disease Therapy Introduction
  13.9.4 Pfizer Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020)
  13.9.5 Pfizer Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Inflammatory Bowel Disease Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Inflammatory Bowel Disease Therapy Revenue
Table 3. Ranking of Global Top Inflammatory Bowel Disease Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Ulcerative Colitis
Table 6. Key Players of Crohns Disease
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Inflammatory Bowel Disease Therapy Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Inflammatory Bowel Disease Therapy Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Inflammatory Bowel Disease Therapy Players to Combat Covid-19 Impact
Table 13. Global Inflammatory Bowel Disease Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Inflammatory Bowel Disease Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Inflammatory Bowel Disease Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Inflammatory Bowel Disease Therapy Market Share by Regions (2015-2020)
Table 17. Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Inflammatory Bowel Disease Therapy Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Inflammatory Bowel Disease Therapy Market Growth Strategy
Table 23. Main Points Interviewed from Key Inflammatory Bowel Disease Therapy Players
Table 24. Global Inflammatory Bowel Disease Therapy Revenue by Players (2015-2020) (Million US$)
Table 25. Global Inflammatory Bowel Disease Therapy Market Share by Players (2015-2020)
Table 26. Global Top Inflammatory Bowel Disease Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Bowel Disease Therapy as of 2019)
Table 27. Global Inflammatory Bowel Disease Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Inflammatory Bowel Disease Therapy Product Solution and Service
Table 30. Date of Enter into Inflammatory Bowel Disease Therapy Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) (Million US$)
Table 33. Global Inflammatory Bowel Disease Therapy Market Size Share by Type (2015-2020)
Table 34. Global Inflammatory Bowel Disease Therapy Revenue Market Share by Type (2021-2026)
Table 35. Global Inflammatory Bowel Disease Therapy Market Size Share by Application (2015-2020)
Table 36. Global Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) (Million US$)
Table 37. Global Inflammatory Bowel Disease Therapy Market Size Share by Application (2021-2026)
Table 38. North America Key Players Inflammatory Bowel Disease Therapy Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Inflammatory Bowel Disease Therapy Market Share (2019-2020)
Table 40. North America Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) (Million US$)
Table 41. North America Inflammatory Bowel Disease Therapy Market Share by Type (2015-2020)
Table 42. North America Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) (Million US$)
Table 43. North America Inflammatory Bowel Disease Therapy Market Share by Application (2015-2020)
Table 44. Europe Key Players Inflammatory Bowel Disease Therapy Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Inflammatory Bowel Disease Therapy Market Share (2019-2020)
Table 46. Europe Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Inflammatory Bowel Disease Therapy Market Share by Type (2015-2020)
Table 48. Europe Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Inflammatory Bowel Disease Therapy Market Share by Application (2015-2020)
Table 50. China Key Players Inflammatory Bowel Disease Therapy Revenue (2019-2020) (Million US$)
Table 51. China Key Players Inflammatory Bowel Disease Therapy Market Share (2019-2020)
Table 52. China Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) (Million US$)
Table 53. China Inflammatory Bowel Disease Therapy Market Share by Type (2015-2020)
Table 54. China Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) (Million US$)
Table 55. China Inflammatory Bowel Disease Therapy Market Share by Application (2015-2020)
Table 56. Japan Key Players Inflammatory Bowel Disease Therapy Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Inflammatory Bowel Disease Therapy Market Share (2019-2020)
Table 58. Japan Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Inflammatory Bowel Disease Therapy Market Share by Type (2015-2020)
Table 60. Japan Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Inflammatory Bowel Disease Therapy Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Inflammatory Bowel Disease Therapy Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Inflammatory Bowel Disease Therapy Market Share (2019-2020)
Table 64. Southeast Asia Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Inflammatory Bowel Disease Therapy Market Share by Type (2015-2020)
Table 66. Southeast Asia Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Inflammatory Bowel Disease Therapy Market Share by Application (2015-2020)
Table 68. India Key Players Inflammatory Bowel Disease Therapy Revenue (2019-2020) (Million US$)
Table 69. India Key Players Inflammatory Bowel Disease Therapy Market Share (2019-2020)
Table 70. India Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) (Million US$)
Table 71. India Inflammatory Bowel Disease Therapy Market Share by Type (2015-2020)
Table 72. India Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) (Million US$)
Table 73. India Inflammatory Bowel Disease Therapy Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Inflammatory Bowel Disease Therapy Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Inflammatory Bowel Disease Therapy Market Share (2019-2020)
Table 76. Central & South America Inflammatory Bowel Disease Therapy Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Inflammatory Bowel Disease Therapy Market Share by Type (2015-2020)
Table 78. Central & South America Inflammatory Bowel Disease Therapy Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Inflammatory Bowel Disease Therapy Market Share by Application (2015-2020)
Table 80. Johnson & Johnson Company Details
Table 81. Johnson & Johnson Business Overview
Table 82. Johnson & Johnson Product
Table 83. Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) (Million US$)
Table 84. Johnson & Johnson Recent Development
Table 85. AbbVie Company Details
Table 86. AbbVie Business Overview
Table 87. AbbVie Product
Table 88. AbbVie Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) (Million US$)
Table 89. AbbVie Recent Development
Table 90. Takeda Pharmaceutical Company Company Details
Table 91. Takeda Pharmaceutical Company Business Overview
Table 92. Takeda Pharmaceutical Company Product
Table 93. Takeda Pharmaceutical Company Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) (Million US$)
Table 94. Takeda Pharmaceutical Company Recent Development
Table 95. Abbott Company Details
Table 96. Abbott Business Overview
Table 97. Abbott Product
Table 98. Abbott Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) (Million US$)
Table 99. Abbott Recent Development
Table 100. Celgene Corporation Company Details
Table 101. Celgene Corporation Business Overview
Table 102. Celgene Corporation Product
Table 103. Celgene Corporation Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) (Million US$)
Table 104. Celgene Corporation Recent Development
Table 105. Innovate Biopharma Company Details
Table 106. Innovate Biopharma Business Overview
Table 107. Innovate Biopharma Product
Table 108. Innovate Biopharma Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) (Million US$)
Table 109. Innovate Biopharma Recent Development
Table 110. Cosmo Pharmaceuticals Company Details
Table 111. Cosmo Pharmaceuticals Business Overview
Table 112. Cosmo Pharmaceuticals Product
Table 113. Cosmo Pharmaceuticals Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) (Million US$)
Table 114. Cosmo Pharmaceuticals Recent Development
Table 115. Gilead Sciences Business Overview
Table 116. Gilead Sciences Product
Table 117. Gilead Sciences Company Details
Table 118. Gilead Sciences Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) (Million US$)
Table 119. Gilead Sciences Recent Development
Table 120. Pfizer Company Details
Table 121. Pfizer Business Overview
Table 122. Pfizer Product
Table 123. Pfizer Revenue in Inflammatory Bowel Disease Therapy Business (2015-2020) (Million US$)
Table 124. Pfizer Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Inflammatory Bowel Disease Therapy Market Share by Type: 2020 VS 2026
Figure 2. Ulcerative Colitis Features
Figure 3. Crohns Disease Features
Figure 4. Others Features
Figure 5. Global Inflammatory Bowel Disease Therapy Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Medical Research Organization Case Studies
Figure 8. Other Case Studies
Figure 9. Inflammatory Bowel Disease Therapy Report Years Considered
Figure 10. Global Inflammatory Bowel Disease Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Inflammatory Bowel Disease Therapy Market Share by Regions: 2020 VS 2026
Figure 12. Global Inflammatory Bowel Disease Therapy Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Inflammatory Bowel Disease Therapy Market Share by Players in 2019
Figure 15. Global Top Inflammatory Bowel Disease Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Bowel Disease Therapy as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Inflammatory Bowel Disease Therapy Revenue in 2019
Figure 17. North America Inflammatory Bowel Disease Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Inflammatory Bowel Disease Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Inflammatory Bowel Disease Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Inflammatory Bowel Disease Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Inflammatory Bowel Disease Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Inflammatory Bowel Disease Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Inflammatory Bowel Disease Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Johnson & Johnson Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2015-2020)
Figure 26. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. AbbVie Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2015-2020)
Figure 28. Takeda Pharmaceutical Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Takeda Pharmaceutical Company Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2015-2020)
Figure 30. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Abbott Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2015-2020)
Figure 32. Celgene Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Celgene Corporation Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2015-2020)
Figure 34. Innovate Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Innovate Biopharma Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2015-2020)
Figure 36. Cosmo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Cosmo Pharmaceuticals Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2015-2020)
Figure 38. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Gilead Sciences Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2015-2020)
Figure 40. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Pfizer Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2015-2020)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed